DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Similarly, fukutin mutation compromises the glycosylation of DAG1, leading to Fukuyama congenital muscular dystrophy, a milder dystroglycanopathy characterized by progressive muscle weakness [54, 55] and brain vessel dysfunction [56].